1. Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction
- Author
-
Hyung Yoon Kim, Kye Hun Kim, Nuri Lee, Hyukjin Park, Jae Yeong Cho, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong, and Jeong Gwan Cho
- Subjects
heart failure ,myocardial infarction ,prognosis ,acute myocardal infarct ,death ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background and objectivesTo investigate the clinical relevance of the timing of heart failure (HF) development on long-term outcome in patients with acute myocardial infarction (AMI).Materials and methodsA total of 1,925 consecutive AMI patients were divided into 4 groups according to the timing of HF development; HF at admission (group I, n = 627), de novo HF during hospitalization (group II, n = 162), de novo HF after discharge (group III, n = 98), no HF (group IV, n = 1,038). Major adverse cardiac events (MACE) defined as the development of death, re-hospitalization, recurrent MI or revascularization were evaluated.ResultsHF was developed in 887 patients (46.1%) after an index AMI. HF was most common at the time of admission for AMI, but the development of de novo HF during hospitalization or after discharge was not uncommon. MACE was developed in 619 out of 1,925 AMI patients (31.7%). MACE was highest in group I, lowest in group IV, and significantly different among groups; 275 out of 627 patients (43.9%) in group I, 64 out of 192 patients (39.5%) in group II, 36 out of 98 patients (36.7%) in group III, and 235 out of 1,038 patients (22.6%) in group IV (P
- Published
- 2023
- Full Text
- View/download PDF